567 related articles for article (PubMed ID: 27783956)
1. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
[TBL] [Abstract][Full Text] [Related]
2. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
3. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
4. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
[TBL] [Abstract][Full Text] [Related]
5. Genome editing for human gene therapy.
Meissner TB; Mandal PK; Ferreira LM; Rossi DJ; Cowan CA
Methods Enzymol; 2014; 546():273-95. PubMed ID: 25398345
[TBL] [Abstract][Full Text] [Related]
6. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
[TBL] [Abstract][Full Text] [Related]
7. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
8. A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells.
Jayavaradhan R; Pillis DM; Malik P
J Mol Biol; 2019 Jan; 431(1):102-110. PubMed ID: 29751014
[TBL] [Abstract][Full Text] [Related]
9. TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells.
Yen J; Fiorino M; Liu Y; Paula S; Clarkson S; Quinn L; Tschantz WR; Klock H; Guo N; Russ C; Yu VWC; Mickanin C; Stevenson SC; Lee C; Yang Y
Sci Rep; 2018 Nov; 8(1):16304. PubMed ID: 30389991
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response.
Nasri M; Mir P; Dannenmann B; Amend D; Skroblyn T; Xu Y; Schulze-Osthoff K; Klimiankou M; Welte K; Skokowa J
Blood Adv; 2019 Jan; 3(1):63-71. PubMed ID: 30622144
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of CRISPR/Cas9 Off-Target Activity in Hematopoietic Stem and Progenitor Cells.
Park SH; Lee CM; Bao G
Methods Mol Biol; 2022; 2429():281-306. PubMed ID: 35507169
[TBL] [Abstract][Full Text] [Related]
12. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
Dever DP; Porteus MH
Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
[TBL] [Abstract][Full Text] [Related]
13. Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells.
Tran NT; Sommermann T; Graf R; Trombke J; Pempe J; Petsch K; Kühn R; Rajewsky K; Chu VT
Cell Rep; 2019 Sep; 28(13):3510-3522.e5. PubMed ID: 31553918
[TBL] [Abstract][Full Text] [Related]
14. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
DeWitt MA; Magis W; Bray NL; Wang T; Berman JR; Urbinati F; Heo SJ; Mitros T; Muñoz DP; Boffelli D; Kohn DB; Walters MC; Carroll D; Martin DI; Corn JE
Sci Transl Med; 2016 Oct; 8(360):360ra134. PubMed ID: 27733558
[TBL] [Abstract][Full Text] [Related]
15. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
[TBL] [Abstract][Full Text] [Related]
16. Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation.
Mir P; Ritter M; Welte K; Skokowa J; Klimiankou M
Methods Mol Biol; 2020; 2115():455-469. PubMed ID: 32006417
[TBL] [Abstract][Full Text] [Related]
17. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
18. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
Xu L; Yang H; Gao Y; Chen Z; Xie L; Liu Y; Liu Y; Wang X; Li H; Lai W; He Y; Yao A; Ma L; Shao Y; Zhang B; Wang C; Chen H; Deng H
Mol Ther; 2017 Aug; 25(8):1782-1789. PubMed ID: 28527722
[TBL] [Abstract][Full Text] [Related]
20. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
